Fingeraftryk
Dyk ned i forskningsemnerne om 'PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma'. Sammen danner de et unikt fingeraftryk.- Sorter
- Vægt
- Alfabetisk
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
Linda Vidarsdottir, Alireza Azimi, Ishani Das, Ingibjorg Sigvaldadottir, Aldwin Suryo Rahmanto, Andreas Petri, Sakari Kauppinen, Christian Ingvar, Göran Jönsson, Håkan Olsson, Marianne Frostvik Stolt, Rainer Tuominen, Olle Sangfelt, Katja Pokrovskaja Tamm, Johan Hansson, Dan Grandér, Suzanne Egyházi Brage*, Per Johnsson*
*Kontaktforfatter
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
6
Citationer
(Scopus)
47
Downloads
(Pure)